The Europe Intrapartum Monitoring Devices Market would witness market growth of 6.3% CAGR during the forecast period (2022-2028).
The electrodes for intrapartum monitoring are either minimally invasive or externally placed. In contrast to the internal monitoring intrapartum electrodes, which include intrauterine pressure catheters and fetal scalp electrodes, the exterior fetal monitoring electrodes comprise transducers for FHR and transducers for uterine contractions. Due to its greater adoption rates and the growing demand for internal monitoring in mothers with gestational diabetes mellitus (GDM) as well as obesity, the use of fetal scalp electrodes has increased.
When external monitors cannot produce the appropriate findings, fetal scalp electrodes (FSE) are used to monitor the fetus in urgent situations. On the area of the fetal body nearest to the birth canal, the FSE is positioned just below the skin. Fetal heart rate monitoring is one of the main components of external fetal monitoring. Doppler ultrasounds are typically used to monitor external FHR. The transducer is positioned on the mother for precise signaling and improved outcomes after palpating and finding the fetus. Auscultation is a recurring procedure that occurs throughout labor and needs the patient to remain still, making delivery challenging. Nonetheless, external monitoring utilizing transducers during low-risk births is considered secure and dependable.
The rising life expectancy and burgeoning female population in Europe are anticipated to open new market expansion opportunities. In addition, maternal and newborn mortality rates in the region have successfully decreased due to the European Health Commission's emphasis on enhancing maternal care across the region. Hence, more governments are focusing on strengthening the care facilities for mothers and children. About 15% of births in the region experience issues during pregnancy and delivery. Preterm birth and fetal hypoxia are the main issues. Despite the widespread use of monitoring, over 30.000 newborns in Europe are predicted to have birth asphyxia each year. As a result, the demand for intrapartum monitoring devices is increasing in the region, boosting the expansion of the market.
The Germany market dominated the Europe Intrapartum Monitoring Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $81.4 Million by 2028. The UK market is anticipated to grow at a CAGR of 5.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.2% during (2022 - 2028).
Based on Product Type, the market is segmented into Monitors and Electrodes. Based on Method, the market is segmented into Non-invasive and Invasive. Based on End User, the market is segmented into Hospitals, Maternity Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Intrapartum Monitoring Devices Market will Hit $1.3 Billion by 2028, at a CAGR of 7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., MindChild Medical, Inc., Arjo AB (Huntleigh Healthcare ltd.), Stalwart Meditech Private Limited, MedGyn Products, Inc., Cardinal Health, Inc., GE HealthCare Technologies, Inc., CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Olympus Corporation.
By Product Type
By Method
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 